Purpose: The purpose of this study was to develop and evaluate nanoemulsion-based gel (nanogel) for transdermal delivery of Flurbiprofen. Among the various excipients tested, oleic acid, tween 80 and ethanol were selected as oil, surfactant, and co-surfactant respectively. Methods: The nanoemulsions region was identified by constructing pseudo-ternary phase diagrams using aqueous phase titration. The prepared nanoemulsion was subjected to different thermodynamic stability study and the nanoemulsion that passed thermodynamic stability tests were evaluated for viscosity, refractive index, droplet size, transmission electron microscopy, and ex-vivo permeation study using human cadaver skin. Results: On the basis of evaluation C1 formulation, which consists of 3.09 % wt/wt of the oil phase, 60.54 % wt/wt of Smix and 36.36 % wt/wt of distilled water were selected as an optimized formulation and were converted to nanogel using chitosan as a gelling agent. Nanogel was evaluated for ex-vivo and in vivo study. The nanogel showed a significant increase in the anti-inflammatory activity as compared to conventional gel. Conclusion: In conclusion, nanogel could be a promising system to improve transdermal delivery of the Flurbiprofen.
Cite this article:
Mohammed Layth Hamzah. Formulation and Evaluation of Flurbiprofen nanogel. Research J. Pharm. and Tech. 2020; 13(11):5183-5188. doi: 10.5958/0974-360X.2020.00906.3
1. Suzuki T, Shinoda M, Osanai Y, Isozaki T. Photochemical reaction of 2-(3-benzoylphenyl) propionic acid (Flurbiprofen with Basic Amino Acids and Dipeptides. J Phys Chem B. 2013;117(33):9662–8.
2. Miller MA, Pisani E. The cost of Unsafe Injections. Vol. 77, Bulletin of the World Health Organization. 1999. p. 808–11.
3. Callaghan TM, Wilhelm KP. A review of ageing and an examination of clinical methods in the assessment of ageing skin. Part 2: Clinical perspectives and clinical methods in the evaluation of ageing skin. Vol. 30, International Journal of Cosmetic Science. 2008. p. 323–32.
4. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. Nano-emulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharm Sci Tech. 2007;8(4):191–9.
5. Singh B, Singh R, Bandyopadhyay S, Kapil R, Garg B. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surfaces B Biointerfaces. 2013;101: 465–74.
6. Zhao JH, Ji L, Wang H, Chen ZQ, Zhang YT, Liu Y, et al. Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo. Int J Nanomedicine. 2011; 6:1611–9.
7. Swarbrick J, Boylan JC. Encyclopedia of Pharmaceutical Technology. Vol. 20, Pharmaceutical Technology. 1996. 23-24 p.
8. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Vol. 64, Advanced Drug Delivery Reviews. 2012. p. 175–93.
9. Muxika A, Etxabide A, Uranga J, Guerrero P, Caba K De. In-ternational Journal of Biological Macromolecules Chitosan as a bioactive polymer: Processing, properties and applications. Int J Biol Macromol [Internet]. 2017; 105:1358–68. Doi: 10.1016/ j.ijbiomac.2017.07.087
10. S. A, S. I. Chitosan and Its Derivatives: A Review in Recent Innovations. Int J Pharm Sci Res. 2015;6(1):14–30.
11. Azuma K, Izumi R, Osaki T, Ifuku S, Morimoto M, Saimoto H, et al. Chitin, Chitosan, and Its Derivatives for Wound Healing: Old and New Materials. J Funct Biomater. 2015;6(1):104–42.
12. Okamoto Y, Kawakami K, Miyatake K, Morimoto M, Shige-masa Y, Minami S. Analgesic effects of chitin and chitosan. Carbohydr Polym. 2002;49(3):249–52.
13. Pathan IB, Mallikarjuna Setty C. Nanoemulsion system for transdermal delivery of tamoxifen citrate: Design, Characterization, effect of penetration enhancers and in vivo studies. Dig J Nanomater Biostructures. 2012;7(4):1373–87.
14. Shafaat K, Kumar B, Das SK, Ul Hasan R, Prajapati SK. Novel nanoemulsion as vehicles for transdermal delivery of Clozapine: In vitro and in vivo studies. Int J Pharm Sci. 2013;5(SUPPL 3):126–34.
15. Soliman SM, Abdel Malak NS, El-Gazayerly ON, Abdel Rehim a a. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: In vitro permeation, an-ti-inflammatory activity and skin irritation tests. Drug Discov. Ther [Internet]. 2010;4(6):459–71.
16. Moreno MA, Ballesteros MP, Frutos P. Lecithin-based oil-in-water microemulsions for parenteral use: Pseudoternary phase diagrams, characterization and toxicity studies. J Pharm Sci. 2003;92(7):1428–37.
17. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ram-ipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66(2):227–43.
18. Bhatt P, Madhav S. A detailed review on nanoemulsion drug delivery system. Int J Pharm Sci Res. 2011;43(2):2292–8.
19. Liu CH, Yu SY. Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery. Colloids Surfaces B Biointerfaces. 2010; 79(2):509–15.
20. Pathan IB, Munde SJ, Shelke S, Ambekar W, Mallikarjuna Set-ty C. Curcumin loaded fish scale collagen-HPMC nanogel for wound healing application: Ex-vivo and In-vivo evaluation. Int J Polym Mater Polym Biomater. 2018;
21. Fang JY, Sung KC, Lin HH, Fang CL. Transdermal iontophoretic delivery of diclofenac sodium from various poly-mer formulations: in vitro and in vivo studies. Int J Pharm. 1999;178(1):83–92.
22. Shakeel F. Criterion for excipients screening in the development of nanoemulsion formulation of three antiinflammatory drugs. Pharm Dev Technol [Internet]. 2010;15(2):131–8.
23. Pathan IB, Jaware BP, Shelke S, Ambekar W. Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitro and in-vivo study. J Drug Deliv Sci Technol. 2018;44.
24. Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Vol. 60, Advanced Drug Delivery Reviews. 2008.p. 625–37.
25. Silva HD, Cerqueira MA, Vicente AA. Influence of surfactant and processing conditions in the stability of oil-in-water nanoemulsions. J Food Eng. 2015; 167:89–98.
26. Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002;91(9):2076â€“89.